Adenocarcinoma of large intestine | Secondary malignant neoplasm of liver | Indication Excision
Item
colorectal adenocarcinoma with metastases confined only to the liver, histologically proven and considered suitable for treatment by surgical resection.
boolean
C1319315 (UMLS CUI [1])
C0494165 (UMLS CUI [2])
C3146298 (UMLS CUI [3,1])
C0728940 (UMLS CUI [3,2])
WHO performance status scale
Item
world health organisation (who) performance status of 0 or 1
boolean
C1298650 (UMLS CUI [1])
Prior Therapy Toxic effect Resolved | Alopecia Adverse Event | Standard toxicity grade 1
Item
all toxic manifestations of previous treatment must have resolved. exceptions to this are alopecia or certain grade 1 toxicities which in the opinion of the investigator and cancer research uk should not exclude the patient.
boolean
C1514463 (UMLS CUI [1,1])
C0600688 (UMLS CUI [1,2])
C3714811 (UMLS CUI [1,3])
C1559115 (UMLS CUI [2])
C1513302 (UMLS CUI [3])
Therapeutic radiology procedure | Hormone Therapy | Immunotherapy | systemic steroids | Chemotherapy | Nitrosourea Compounds | Mitomycin
Item
radiotherapy, endocrine therapy, immunotherapy, systemic steroids, or chemotherapy during the previous four weeks (six weeks for nitrosoureas and mitomycin-c) prior to treatment or during the course of the trial.
boolean
C1522449 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C2825233 (UMLS CUI [4])
C0392920 (UMLS CUI [5])
C0028210 (UMLS CUI [6])
C0002475 (UMLS CUI [7])
High risk Medical Due to Systemic disease Non-Malignant | Communicable Disease Uncontrolled
Item
patients who are high medical risks because of non-malignant systemic disease, including those with active uncontrolled infection.
boolean
C0332167 (UMLS CUI [1,1])
C0205476 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0442893 (UMLS CUI [1,4])
C1518371 (UMLS CUI [1,5])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Communicable Diseases Serious
Item
concurrent serious infections within the 28 days prior to entry to the trial
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Malignant Neoplasms Site | Carcinoma in situ of uterine cervix Conization Treated Adequate | Basal cell carcinoma | Squamous cell carcinoma of skin
Item
current malignancies at other sites, with the exception of adequately treated cone-biopsied in situ carcinoma of the cervix uteri and basal or squamous cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
C0851140 (UMLS CUI [2,1])
C0195324 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C0205411 (UMLS CUI [2,4])
C0007117 (UMLS CUI [3])
C0553723 (UMLS CUI [4])
Hepatitis B positive Serologic | Hepatitis C positive Serologic | HIV Seropositivity
Item
patients known to be serologically positive for hepatitis b, c or hiv
boolean
C0856706 (UMLS CUI [1,1])
C0205473 (UMLS CUI [1,2])
C1112419 (UMLS CUI [2,1])
C0205473 (UMLS CUI [2,2])
C0019699 (UMLS CUI [3])
Hypersensitivity Vaccination | Hypersensitivity Egg Proteins
Item
history of allergy to vaccinations or egg proteins.
boolean
C0020517 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013700 (UMLS CUI [2,2])
Inflammatory Bowel Disease
Item
inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
Autoimmune Disease
Item
history of autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Cerebral metastasis Evidence Clinical
Item
clinical evidence of cerebral metastases
boolean
C0555278 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])